Skip to content

Intervention of Exercise and Atorvastatin Drug On Heart Natriuretic peptides.

Clinical Trials Of Comparative Effect Exercise And Atorvastatin Drug Upon Natriuretic Peptides In Cardiovascular Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017060633030N2
Enrollment
40
Registered
2017-06-15
Start date
2017-06-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHD. Chronic ischaemic heart disease

Interventions

Intervention 1: Intervention Group: Atorvastatin Drog,Hydroxy methyl Glutarat , 14 Hours Half Life, 20 Mg- One Dose Per Day, For 12 Weeks,After dinner will be eaten, LOGHMANDrug Company. Intervention
Atorvastatin Drog,Hydroxy methyl Glutarat , 14 Hours Half Life, 20 Mg- One Dose Per Day, For 12 Weeks,After dinner will be eaten, LOGHMANDrug Company
. Intervention 4: Control Group: Without Exercise and Without Taking medication.
Treatment - Drugs
Rehabilitation
Treatment - Other
Intervention Group: Atorvastatin Drog,Hydroxy methyl Glutarat , 14 Hours Half Life, 20 Mg- One Dose Per Day, For 12 Weeks,After dinner will be eaten, LOGHMANDrug Company
Intervention Exercise Group: Aerobic Exercise Including Walking on the water and Carnal swiming, For 12 Weeks,Three Sessions of Exercise per Week, 50 to 65 % Intensity VO2 Max,Controled with Polar He
Intervention Group,Exercise and Atorvastatin:Aerobic Exercise Including Walking on the water and Carnal swiming, For 12 Weeks,Three Sessions of Exercise per Week, 50 to 65 % Intensity VO2 Max,Controle
Atorvastatin Drog,Hydroxy methyl Glutarat , 14 Hours Half Life, 20 Mg- One Dose Per Day, For 12 Weeks,After dinner will be eaten, LOGHMANDrug Company
Control Group: Without Exercise and Without Taking medication.

Sponsors

Medical Science of Shiraz
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria; Cardiovascular Patients With At least 30% Stenosis And a History Of Hospital Admission Have to be Considered Criteria Were Selected. Exclusion Criteria; Not respecting the Recommendations of the Study, the Researchers, Causing Serious Illness or lack of Desire to Continue Research Will be Considered.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Brain Natriuretic Peptides. Timepoint: Pre Intervention and 12 Weeks Post Intervention. Method of measurement: Pg/ML With ELISA Method.;Atrum Natriuretic Peptides. Timepoint: Pre Intervention and 12 Weeks Post Intervention. Method of measurement: Pg/ML With ELISA Method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr,Mohsendavoodi

Medical Science of Shiraz

mdavoodi827@gmail.com+98 71 3212 2313

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026